Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Capital One Financial I Pref | COF-I | 7. nov 2024 | 21.10 | +0.67 |
Capital One Financial J Pref | COF-J | 7. nov 2024 | 19.95 | +0.40 |
Capital One Financial K Pref | COF-K | 7. nov 2024 | 20.15 | +1.00 |
Capital One Financial L Pref | COF-L | 7. nov 2024 | 19.23 | +1.21 |
Capital One Financial N Pref | COF-N | 7. nov 2024 | 18.37 | +0.55 |
Capital Southwest | CSWC | 7. nov 2024 | 23.31 | +2.42 |
Capitol Federal Financial | CFFN | 7. nov 2024 | 6.93 | -3.48 |
Capri Holdings | CPRI | 7. nov 2024 | 21.99 | -0.05 |
Capricor Therapeutics | CAPR | 7. nov 2024 | 18.85 | +3.40 |
Captivision | CAPT | 7. nov 2024 | 1.39 | +1.46 |
Cara Therapeutics | CARA | 7. nov 2024 | 0.34 | +10.83 |
Caravelle International Group | CACO | 7. nov 2024 | 0.44 | 0.00 |
Carbon Revolution | CREV | 7. nov 2024 | 3.59 | +12.19 |
Cardiff Oncology | CRDF | 7. nov 2024 | 4.09 | +7.35 |
Cardinal Health | CAH | 7. nov 2024 | 118.22 | +2.28 |
Cardio Diagnostics | CDIO | 7. nov 2024 | 0.43 | +18.51 |
Cardiol Therapeutics | CRDL | 7. nov 2024 | 2.07 | +7.25 |
Cardlytics | CDLX | 7. nov 2024 | 4.07 | -21.88 |
CareCloud | CCLD | 7. nov 2024 | 2.42 | +1.68 |
CareCloud A Pref | CCLDP | 7. nov 2024 | 12.17 | +1.38 |
CareCloud B Pref | CCLDO | 7. nov 2024 | 12.30 | -1.00 |
CareDx | CDNA | 7. nov 2024 | 23.88 | +2.89 |
CareMax A | CMAX | 7. nov 2024 | 2.09 | +3.47 |
CareTrust REIT | CTRE | 7. nov 2024 | 30.67 | +4.00 |
CARGO Therapeutics | CRGX | 7. nov 2024 | 21.49 | +1.03 |
CarGurus A | CARG | 7. nov 2024 | 33.36 | +1.43 |
Caribou Biosciences | CRBU | 7. nov 2024 | 2.78 | +1.09 |
Carisma Therapeutics | CARM | 7. nov 2024 | 1.03 | -7.21 |
Carlisle Companies | CSL | 7. nov 2024 | 448.65 | -0.44 |
Carlyle Credit Income Fund | CCIF | 7. nov 2024 | 8.21 | +0.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.